[Biological response modifiers and urological cancer].
Ohmori
H
H
Tazaki
H
H
D002292:Carcinoma, Renal Cell / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016219:Immunotherapy, Adoptive; D007680:Kidney Neoplasms / Q000628:therapy; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation; D001749:Urinary Bladder Neoplasms / Q000628:therapy; D014571:Urologic Neoplasms / Q000628:therapy*
D007155:Immunologic Factors